The Patent Finder

Pathologica LLC

Also on record
Records under this name other than the patents Pathologica LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Pathologica LLC

PatentTitleStatus Expires Confidence
US 10,085,955Methods and Compositions for Treatment of Demyelinating Diseases
Lapsed on the fee record
Ended Oct 2, 2026 · High confidence
Lapsed on the fee recordEnded Oct 2, 2026High confidence
US 9,867,794Regulation of osteopontin
Lapsed on the fee record
Ended Jan 16, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 16, 2026From the USPTO record
US 8,609,734Methods of treating pain with MGBG
Lapsed on the fee record
Ended Dec 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 17, 2025From the USPTO record
US 9,675,566Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing
Lapsed on the fee record
Ended Jun 13, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 13, 2025From the USPTO record
US 9,668,988Controlled release oral pharmaceutical dosage forms comprising MGBG
Lapsed on the fee record
Ended Jun 6, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2025From the USPTO record
US 8,445,540Regulation of osteopontin
Lapsed on the fee record
Ended May 21, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 21, 2025From the USPTO record
US 9,616,035Pharmaceutical for oral delivery comprising MGBG and methods of treating disease
Lapsed on the fee record
Ended Apr 11, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 11, 2025From the USPTO record
US 10,881,626Controlled release oral pharmaceutical dosage forms comprising MGBG
Lapsed on the fee record
Ended Jan 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 5, 2025From the USPTO record
US 8,258,186Pharmaceutical for oral delivery comprising MGBG
Lapsed on the fee record
Ended Sep 4, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 4, 2024From the USPTO record
US 10,350,178Methods and Compositions for Treatment of Demyelinating Diseases
Lapsed on the fee record
Ended Jul 16, 2023 · High confidence
Lapsed on the fee recordEnded Jul 16, 2023High confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited